Table 1 Baseline characteristics of participants according to their MIND diet score.

From: Association Between MIND Diet Adherence and Mortality: Insights from Diabetic and Non-Diabetic Cohorts

  

MIND diet score

 

Characteristics

Total (N = 6887)

Low (N = 3846)

High (N = 3041)

P-value

Age (years)

47.13 ± 0.45

45.04 ± 0.43

49.66 ± 0.61

< 0.0001

Sex, n (%)

   

< 0.0001

Male

3181(46.19)

1927(50.80)

1254(39.13)

 

Female

3706(53.81)

1919(49.20)

1787(60.87)

 

Race/ethnicity, n (%)

   

< 0.001

Non-Hispanic White

3809(55.31)

2073(70.52)

1736(75.53)

 

Non-Hispanic Black

1333(19.36)

847(13.64)

486(8.67)

 

Mexican American

1272(18.47)

671(7.74)

601(8.20)

 

Others

473(6.87)

255(8.10)

218(7.60)

 

Education level, n (%)

   

< 0.0001

Less than high school

1831(26.59)

1143(19.48)

688(12.50)

 

High school or equivalent

1730(25.12)

1079(30.83)

651(21.49)

 

College or above

3326(48.29)

1624(49.68)

1702(66.01)

 

Family income to poverty ratio, n (%)

   

< 0.0001

< 1

1077(15.64)

679(13.06)

398(8.82)

 

≥ 1 & < 3

2781(40.38)

1636(37.41)

1145(31.55)

 

≥ 3

2715(39.42)

1352(45.02)

1363(56.08)

 

Unknown

314(4.56)

179(4.51)

135(3.55)

 

Smoking status, n (%)

   

< 0.0001

Never

3526(51.2)

1887(46.69)

1639(53.92)

 

Former

1920(27.88)

963(22.55)

957(30.43)

 

Current

1441(20.92)

996(30.76)

445(15.65)

 

BMI (kg/m2), n (%)

   

0.07

< 25.0

2082(30.71)

1141(33.70)

941(33.80)

 

25.0–29.9

2356(34.75)

1274(31.64)

1082(34.85)

 

≥ 30.0

2341(34.53)

1370(34.66)

971(31.35)

 

Physical activity, n (%)

   

< 0.0001

Sedentary

1774(25.76)

1114(21.93)

660(15.03)

 

Insufficient

2621(38.06)

1454(41.57)

1167(41.41)

 

Moderate

1129(16.39)

591(16.74)

538(19.04)

 

High

1363(19.79)

687(19.77)

676(24.52)

 

Diabetes, n (%)

1021(14.83)

581(11.04)

440(10.78)

0.79

Hypertension, n (%)

2984(43.33)

1687(38.06)

1297(38.27)

0.92

Hyperlipidemia, n (%)

4954(71.93)

2775(70.09)

2179(69.96)

0.93

Heart failure

264(3.83)

166(2.87)

98(2.34)

0.37

Ischemic heart disease

498(7.24)

289(5.81)

209(5.10)

0.32

Myocardial infarction

361(5.24)

211(4.25)

150(3.65)

0.63

TC (mg/dL)

200.23 ± 0.70

198.60 ± 0.76

202.20 ± 1.25

0.02

TG (mg/dL)

142.74 ± 2.53

145.97 ± 3.38

138.86 ± 4.20

0.22

LDL-C (mg/dL)

115.77 ± 0.84

115.81 ± 1.25

115.72 ± 1.33

0.96

HbA1C (%)

5.47 ± 0.02

5.47 ± 0.02

5.46 ± 0.02

0.48

Fasting glucose (mg/dL)

5.65 ± 0.04

5.63 ± 0.05

5.68 ± 0.06

0.38

eGFR (mL/min/1.73 m2)

93.13 ± 0.66

94.95 ± 0.60

90.91 ± 0.84

< 0.0001

Waist circumference (cm)

97.53 ± 0.45

98.21 ± 0.47

96.71 ± 0.63

0.03

Energy intake (Kcal)

2117.02 ± 15.62

2159.73 ± 17.75

2065.08 ± 23.42

0.001

DAPT

8(0.12)

4(0.09)

4(0.04)

0.40

Statin therapy

1073(15.59)

576(13.13)

497(13.95)

0.45

Hypoglycemic treatment

630(9.16)

357(6.62)

273(6.58)

0.94

  1. Data are presented as weighted means ± SEs for continuous variables and unweighted numbers (weighted percentages) for categorical variables.
  2. MIND diet Mediterranean-DASH Diet Intervention for Neurodegenerative Delay diet, BMI Body mass index, TC Total cholesterol, TG Triglyceride, LDL-C Low-density lipoprotein cholesterol, HDL-C High-density lipoprotein cholesterol, HbA1c Glycosylated hemoglobin, type A1C; eGFR estimated glomerular filtration rate, DAPT Dual antiplatelet therapy.